Author

Rambabu Gundla

Observed names: Gundla Rambabu, Gundla, R., Gundla, Rambabu, R. Gundla, RAMBABU GUNDLA, Rambabu GUNDLA

Observed institutions: Andhra University, University of Southern California, Shiv Nadar University, GVK (India), USC Norris Comprehensive Cancer Center, GITAM University

ORCID: 0000-0003-0390-6505

Observed ORCIDs: 0000-0003-0390-6505, 0000-0002-6469-6022

OpenAlex ID: A5070305207

Discovery of Novel Small-Molecule Inhibitors of Human Epidermal Growth Factor Receptor-2: Combined Ligand and Target-Based Approach

2008 · Rambabu Gundla, Roza Kazemi, et al. · Journal of Medicinal Chemistry · 137

HIV‐1 integrase inhibitors: 2005–2006 update

2007 · Raveendra Dayam, Rambabu Gundla, et al. · Medicinal Research Reviews · 100

Synthesis, Biological Evaluation and Docking Studies of 1,3,4-Oxadiazole Fused Benzothiazole Derivatives for Anticancer Drugs

2018 · Madala Subramanyam, Reddymasu Sreenivasulu, et al. · Letters in Drug Design & Discovery · 64

Molecular hybrid design, synthesis and biological evaluation of N-phenyl sulfonamide linked N-acyl hydrazone derivatives functioning as COX-2 inhibitors: new anti-inflammatory, anti-oxidant and anti-bacterial agents

2017 · Vasubabu Gorantla, Rambabu Gundla, et al. · New Journal of Chemistry · 55

Ionic liquid/water mixture promoted organic transformations

2015 · Pedavenkatagari Narayana Reddy, Pannala Padmaja, et al. · RSC Advances · 53

Focused library design and synthesis of 2-mercapto benzothiazole linked 1,2,4-oxadiazoles as COX-2/5-LOX inhibitors

2018 · Satayanarayana Yatam, Rambabu Gundla, et al. · Journal of Molecular Structure · 47

Development and Validation of a Stability-indicating Method for Ibrutinib: Identification and Separation of Degradation Products, Known and Genotoxic Impurities Using RP-HPLC/PDA and QDa Mass Detectors

2020 · Naresh Konduru, Rambabu Gundla, et al. · Analytical Chemistry Letters · 46

A simple high‐performance liquid chromatography method development for Carbidopa and Levodopa impurities: Evaluation of risk assessment before method validation by Quality by Design approach

2020 · Velusamy B. Subramanian, Naresh Konduru, et al. · Separation Science Plus · 45

Design, Synthesis and Biological Evaluation of 2 (((5‐aryl‐1,2,4‐oxadiazol‐3‐yl)methyl)thio)benzo[d]oxazoles: New Antiinflammatory and Antioxidant Agents

2018 · Satyanarayana Yatam, Surender Singh Jadav, et al. · ChemistrySelect · 44

Rational design, molecular docking and synthesis of novel homopiperazine linked imidazo[1,2-a]pyrimidine derivatives as potent cytotoxic and antimicrobial agents

2019 · Manohar Mantipally, Madhusudhana Reddy Gangireddy, et al. · Bioorganic & Medicinal Chemistry Letters · 43

Discovery of 3-acetyl-4-hydroxy-2-pyranone derivatives and their difluoridoborate complexes as a novel class of HIV-1 integrase Inhibitors

2008 · Kavya Ramkumar, Konstantin V. Tambov, et al. · Bioorganic & Medicinal Chemistry · 42

Fibroblast Growth Factor Receptor Inhibitors

2012 · Suneel Kumar B.V.S, Lakshmi Narasu, et al. · Current Pharmaceutical Design · 41

Synthesis, Cytotoxicity and Molecular Docking Studies of Chalcone Incorporated 1,2,3-Triazol-1,3,5-Triazin-Quinazoline as Anti-Cancer Agents

2022 · Sujana Oggu, Bala Divya Mallavarapu, et al. · Journal of Molecular Structure · 36

Discovery and Preclinical Evaluation of a Novel Class of Cytotoxic Propynoic Acid Carbamoyl Methyl Amides (PACMAs)

2011 · Roppei Yamada, Xuefei Cao, et al. · Journal of Medicinal Chemistry · 36

Development and validation of liquid chromatography method for determination of Ibrutinib in finished dosage forms using quality by design approach

2022 · Naresh Konduru, Rambabu Gundla, et al. · Separation Science Plus · 34

Design and Synthesis of Piperazine‐Linked Imidazo[1,2‐ a ]pyridine Derivatives as Potent Anticancer Agents

2019 · Madhusudhana Reddy Gangireddy, Manohar Mantipally, et al. · ChemistrySelect · 34

Development and validation of novel RP‐HPLC method for midostaurin determination using analytical quality by design approach from regulatory perspective and determination of major degradation compounds of midostaurin using LC–MS

2022 · Madhu Prakash Reddy Saddala, Naresh Konduru, et al. · Biomedical Chromatography · 31

Design, synthesis, and biological evaluation of quinazoline derivatives as α-glucosidase inhibitors

2014 · Venkateshwarlu Gurram, Ramesh Garlapati, et al. · Medicinal Chemistry Research · 31

Favipiravir (SARS‐CoV‐2) degradation impurities: Identification and route of degradation mechanism in the finished solid dosage form using LC/LC–MS method

2022 · Divya Kumar Vemuri, Rambabu Gundla, et al. · Biomedical Chromatography · 27

Design, synthesis and biological evaluation of selective hybrid coumarin-thiazolidinedione aldose reductase-II inhibitors as potential antidiabetics

2021 · Vijay Kumar Pasala, Gopinath Gudipudi, et al. · Bioorganic Chemistry · 26

Unique liquid chromatography technique for the determination of mirabegron in the presence of polymers; robustness by Design Expert in the light of Quality by Design

2022 · Naresh Konduru, Leela Prasad Kowtharapu, et al. · Biomedical Chromatography · 25

Synthesis, molecular docking, antiproliferative, and antimicrobial activity of novel pyrano[3,2-c]carbazole derivatives

2016 · Pedavenkatagari Narayana Reddy, Pannala Padmaja, et al. · Medicinal Chemistry Research · 25

Unique Quality by Design Approach for Developing HPLC and LC-MS Method for Estimation of Process and Degradation Impurities in Pibrentasvir, Antiviral Agent for Hepatitis C

2022 · Divya Kumar Vemuri, Parameswari Akshinthala, et al. · ACS Omega · 24

Recent Literature Review on Coumarin Hybrids as Potential Anticancer Agents

2022 · Naresh Kumar Katari, Muhammad D. Bala, et al. · Anti-Cancer Agents in Medicinal Chemistry · 24

Development of α-glucosidase inhibitors by room temperature C–C cross couplings of quinazolinones

2013 · Ramesh Garlapati, Narender Pottabathini, et al. · Organic & Biomolecular Chemistry · 24

Works count: 165

Citation count: 1,895

H-index: 24

I10-index: 60